Limited Utility of Surveillance Imaging for Detecting Disease Relapse in Patients With Non-Hodgkin Lymphoma in First Complete Remission

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2013.08.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prophylactic Cranial Irradiation for Patients With Limited Disease Small Cell Lung Cancer in Complete Remission.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
1997English

Utilities for Health States in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma and Factors Influending Utility Values

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Remission and Relapse of Crohn's Disease Following Autologous Haematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma

Gut
Gastroenterology
2007English

Epidemiology of Chemotherapy-Induced Anemia in Patients With Non-Hodgkin Lymphoma

Permanente journal,The
Medicine
2019English

Venetoclax (Ven) in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma (Nhl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Treatment of Relapse and Refractory Hodgkin Lymphoma

Oncogematologiya
OncologyHematology
2017English

Risk of HBV Liver Disease in Isolated antiHbc Patients Receiving Immuno-Chemotherapy for Non Hodgkin Lymphoma

Haematologica
Hematology
2008English

Rituximab Maintenance for Patients With Diffuse Large B-Cell Lymphoma in First Complete Remission: Results From a Randomized Hovon-Nordic Lymphoma Group Phase Iii Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The Benefit of Consolidation Radiotherapy to Initial Disease Bulk in Patients With Advanced Hodgkin's Disease Who Achieved Complete Remission After Standard Chemotherapy

Journal of Blood Medicine
Hematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy